Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
about
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled TrialsPresent and future in the treatment of diabetic kidney diseaseOral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas diseaseClinical therapeutic strategies for early stage of diabetic kidney disease.Disease-dependent mechanisms of albuminuria.Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathyAngiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic ratsComparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats Kidneys Transfected with Adenovirus-mediated Fibromodulin GeneSignificance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Transforming growth factor-β1 and diabetic nephropathyBiomolecular basis of the role of diabetes mellitus in osteoporosis and bone fracturesDiabetes and Kidney Disease: Role of Oxidative Stress.TGF-beta signal transduction in chronic kidney diseaseThe genetics of diabetic nephropathy.Effects of Averrhoa carambola L. (Oxalidaceae) juice mediated on hyperglycemia, hyperlipidemia, and its influence on regulatory protein expression in the injured kidneys of streptozotocin-induced diabetic mice.Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium.Role of megalin and cubilin in the metabolism of vitamin D(3).Immunochemically unreactive albumin in urine: fiction or reality?Transforming growth factor-β/Smad signalling in diabetic nephropathy.What are new avenues for renal protection, in addition to RAAS inhibition?Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction.Therapeutic approaches to diabetic nephropathy--beyond the RAS.New molecular insights in diabetic nephropathy.Kidney Injury Molecule-1 Enhances Endocytosis of Albumin in Renal Proximal Tubular Cells.The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells.CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies.Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathyUrocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF.Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-β1 in streptozotocin-induced diabetic rat model.Proximal tubule cell hypothesis for cardiorenal syndrome in diabetes.Effect of Cyclophosphamide on Expression of MMP-9 and TGF-β1 in Renal Tissue of Rats with Diabetes Mellitus.The assessment of early glycosaminoglycan concentration changes in the kidney of diabetic rats by critical electrolyte concentration staining.Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
P2860
Q26768469-E6397243-2C74-4689-8D79-80F3BA4BC7A1Q26864133-C6E7E00C-81FF-4299-B43C-CB12C7BB99F0Q28484212-92337B2C-B190-4693-BFD8-EA672F200AFEQ30363683-0AB7D425-5819-4ACB-BD94-9BC42FFE6909Q34012444-98B4CF5A-7CAD-4EEB-A355-C4616B00570EQ34563204-6C8C7810-5AF2-4E88-9EEF-9E1BCED3D966Q34979668-D07FBA66-8570-4F48-BAAA-2FBF16E3AD21Q35056916-0C1D4D33-E108-417E-B9F4-426AE320F7FAQ35169750-3331D0CF-1D0A-48B0-B828-B5FE3B263F5CQ35898292-D51FC625-DE14-4C65-9430-152511C039AAQ35927429-265C347F-8A8B-4966-B664-A6422ED04F67Q35956447-FAB87862-C638-46C6-8873-904B038C62C7Q35994939-AACE2800-ECA7-49C2-9C2B-FD04E1A6103FQ36810701-BC3D2820-08DD-499C-9469-D7E22BF91F9FQ37101614-1CB751EF-2D12-4892-8BC6-0D34F2172164Q37349206-14992584-DAE2-4DAA-A34D-913332A924BCQ37410310-21395825-34BF-42E2-A7A7-FD3375AD6928Q37590421-88AE7099-9B61-412B-9D80-6A5D0DE04CBCQ37596859-F37532E5-1360-4ABC-BD31-E2B1C5ACDF97Q37654819-4C66CCFF-75AE-428F-99B0-A2967376C617Q37877297-FDD3FB7B-FB00-4501-8B24-C3FC9E743850Q37922794-9E1800F0-F1F7-4929-AAAE-3A998F676966Q37972665-19C7EF12-040A-4376-85CC-D2507123649BQ37980677-97DB597D-708F-42D1-B77D-8B6A3E5517A6Q37998392-A0B25C72-7794-4C4F-95A4-7B4EE582A107Q38209811-7AB625A6-A09A-4F47-A049-EFB7BEF94E8BQ38694219-DA10D400-9442-414E-AB58-CC4E11259AB5Q38838553-5D901F09-E029-4478-AC22-39F141991FB1Q39160284-B3CDD468-4DAA-4FD3-B224-BEF2B3FAB9FCQ39315427-A34B74E1-FC09-4E1B-B62E-8E8D53748E59Q39408463-893C703A-CE23-47F5-AA8E-AAFD69511BCDQ39847514-62B866B8-C4EC-40FA-A151-D97B8974024DQ40258073-739A3B18-F614-4763-97A1-FC969EB6F842Q41295481-C9DFCEC0-374F-4AFE-9FA6-444CC286A537Q41629681-F84F343D-2A3F-456D-B631-3B933DE9BBE8Q41945001-1274D674-598D-4D14-AA20-A258ECD8B407Q42074338-3235BC12-CACD-4119-B0C0-329FE2F274B3Q42707950-608751C6-BEDA-4BF7-9B69-7E125DEE0623Q42710874-413033B6-780E-441D-BC69-F6763475EC9AQ43297018-9C0C89B1-49F1-44B3-934F-F6C0ADB702FC
P2860
Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Evidence for a role of transfo ...... ble TGF-beta type II receptor.
@en
Evidence for a role of transforming growth factor
@nl
type
label
Evidence for a role of transfo ...... ble TGF-beta type II receptor.
@en
Evidence for a role of transforming growth factor
@nl
prefLabel
Evidence for a role of transfo ...... ble TGF-beta type II receptor.
@en
Evidence for a role of transforming growth factor
@nl
P2093
P356
P1433
P1476
Evidence for a role of transfo ...... ble TGF-beta type II receptor.
@en
P2093
Dennis Brown
Elisabetta del Re
Herbert Y Lin
Leileata M Russo
P304
P356
10.2337/DB06-1018
P407
P577
2007-02-01T00:00:00Z